PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 69 filers reported holding PROQR THRAPEUTICS N V in Q3 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,574,000 | -4.3% | 321,360 | 0.0% | 0.08% | +1.2% |
| Q3 2021 | $2,690,000 | +24.2% | 321,360 | 0.0% | 0.08% | +22.7% |
| Q2 2021 | $2,166,000 | +2.0% | 321,360 | 0.0% | 0.07% | -1.5% |
| Q1 2021 | $2,124,000 | +109.5% | 321,360 | +33.1% | 0.07% | +97.1% |
| Q4 2020 | $1,014,000 | -4.3% | 241,360 | +9.0% | 0.03% | -20.9% |
| Q3 2020 | $1,060,000 | -21.2% | 221,360 | 0.0% | 0.04% | -27.1% |
| Q2 2020 | $1,346,000 | +10.8% | 221,360 | 0.0% | 0.06% | -11.9% |
| Q1 2020 | $1,215,000 | -44.6% | 221,360 | 0.0% | 0.07% | -27.2% |
| Q4 2019 | $2,194,000 | +89.1% | 221,360 | +9.9% | 0.09% | +84.0% |
| Q3 2019 | $1,160,000 | -36.7% | 201,360 | 0.0% | 0.05% | -41.2% |
| Q2 2019 | $1,832,000 | -33.6% | 201,360 | +1.2% | 0.08% | -33.1% |
| Q1 2019 | $2,761,000 | -3.5% | 199,060 | +9.8% | 0.13% | -7.3% |
| Q4 2018 | $2,862,000 | -22.7% | 181,360 | -5.2% | 0.14% | -18.5% |
| Q3 2018 | $3,703,000 | +165.1% | 191,360 | 0.0% | 0.17% | +205.5% |
| Q2 2018 | $1,397,000 | +137.6% | 191,360 | 0.0% | 0.06% | +129.2% |
| Q1 2018 | $588,000 | -4.7% | 191,360 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $617,000 | -33.5% | 191,360 | 0.0% | 0.02% | -31.4% |
| Q3 2017 | $928,000 | -6.7% | 191,360 | 0.0% | 0.04% | -2.8% |
| Q2 2017 | $995,000 | +4.0% | 191,360 | 0.0% | 0.04% | +9.1% |
| Q1 2017 | $957,000 | -7.3% | 191,360 | -9.1% | 0.03% | -13.2% |
| Q4 2016 | $1,032,000 | -26.5% | 210,556 | 0.0% | 0.04% | -25.5% |
| Q3 2016 | $1,404,000 | +41.5% | 210,556 | +2.7% | 0.05% | +82.1% |
| Q2 2016 | $992,000 | -0.8% | 205,000 | 0.0% | 0.03% | 0.0% |
| Q1 2016 | $1,000,000 | -43.8% | 205,000 | 0.0% | 0.03% | -39.1% |
| Q4 2015 | $1,779,000 | +16.3% | 205,000 | +95.2% | 0.05% | +31.4% |
| Q3 2015 | $1,530,000 | -6.2% | 105,000 | +7.3% | 0.04% | +6.1% |
| Q2 2015 | $1,632,000 | +39.6% | 97,890 | +83.2% | 0.03% | +32.0% |
| Q1 2015 | $1,169,000 | – | 53,436 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
| Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
| RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
| Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
| Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
| COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
| Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
| APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
| ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |